PF-Atlas › Clinical Trials › NCT02625246

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis

hMSCs · Phase 1

Registry ID

NCT02625246

Phase

Phase 1

Status

Completed

Drug / intervention

hMSCs

Sponsor

Marilyn Glassberg

Start

2016-02-04

Enrollment

Locations

About this trial

To demonstrate the safety of bone marrow-derived allogeneic human Mesenchymal Stem Cells (hMSCs) in patients with bronchiectasis receiving standard of care therapy, and to explore treatment efficacy

View NCT02625246 on ClinicalTrials.gov →

Explore related

All hMSCs trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02625246 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.